Methods and compositions using complement fixing monoclonal antibody to human T cells
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 31, 1987
Issued Date -
N/A
app pub date -
Mar 6, 1985
filing date -
Apr 26, 1979
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Hybrid cell line for production of monoclonal antibody to an antigen found on all normal human T cells and cutaneous T lymphoma cells. The hybrid is formed by fusing splenocytes from immunized CAF.sub.1 mice with P3X63Ag8U1 myeloma cells. Diagnostic and therapeutic uses of the monoclonal antibody are also disclosed.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully